Product Information
CLOZAPINE ODT 200 MG TABLET is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $21.2033 per EA under NDC 00093537701. Its NADAC has been published 129 times since Apr 17, 2024.
FDA first approved this application on Nov 25, 2015. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
200 mg/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00093537701
Classification
Generic
Dosage Form
TABLET, ORALLY DISINTEGRATING
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
CLOZAPINEApproval Type
Generic (ANDA)
FDA Application
ANDA090308FDA Approved
11/25/2015
TE Code
AB
On Market Since
7/30/2020
Pharmacological Classes
Price Statistics
The NADAC for CLOZAPINE ODT 200 MG TABLET has been published 129 times since Apr 17, 2024, and over the history we have for it it has risen 7.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $21.2033 per EA |
|---|---|
| All-time high | $21.4812 (Sep 10, 2025) |
| All-time low | $18.6485 (Oct 23, 2024) |
| 52-week high | $21.2349 |
| 52-week low | $20.4709 |
| Median price | $20.4884 |
| Average price | $20.2223 |
| Largest weekly change | -4.0% (Sep 18, 2024) |
| Weeks tracked | 129 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 95% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Teva Pharmaceuticals USA Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Clozapine market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Atypical Antipsychotic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CLOZAPINE ODT 200 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CLOZAPINE ODT 200 MG TABLET, manufactured by Teva Pharmaceuticals USA Inc., is $21.2033 per EA (NDC 00093537701), effective Sep 30, 2026.
How has the price of CLOZAPINE ODT 200 MG TABLET changed over time?
Over the history we have for it, the NADAC for CLOZAPINE ODT 200 MG TABLET has risen 7.4%. It has been tracked across 129 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for CLOZAPINE ODT 200 MG TABLET?
Since Apr 17, 2024, the NADAC for CLOZAPINE ODT 200 MG TABLET has ranged from a low of $18.6485 (Oct 23, 2024) to a high of $21.4812 (Sep 10, 2025), with a median of $20.4884 per EA.
Are there cheaper alternatives to CLOZAPINE ODT 200 MG TABLET?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CLOZAPINE 200 MG TABLET, is $0.9689 per EA — about 95% below CLOZAPINE ODT 200 MG TABLET.
Who manufactures CLOZAPINE ODT 200 MG TABLET?
CLOZAPINE ODT 200 MG TABLET (NDC 00093537701) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.